Skip to main content
. Author manuscript; available in PMC: 2015 Mar 19.
Published in final edited form as: Ann Thorac Surg. 2012 Feb;93(2):429–437. doi: 10.1016/j.athoracsur.2011.10.061

Fig 2.

Fig 2

Kaplan-Meier curves of recurrence-free survival rates for 10 esophageal cancer patients staged as cT2 N0 who underwent operations alone vs 50 cT2 N0 patients who received neoadjuvant chemoradiation therapy, followed by an operation, with 5-year recurrence-free survival rates of 80% vs 63%, respectively. This analysis excluded 7 patients who were margin-positive and 2 patients with unknown margin status.